Bioinformatics Software | QIAGEN Digital Insights

QIAGEN Ingenuity Pathway Analysis (IPA) summer camp - Session#2
2024-07-10 13:00 - 14:00 (America/Halifax) | Virtual - Americas - EST, United States
Join us for three 60-minute training sessions for QIAGEN Ingenuity Pathway Analysis (IPA).

In this training, you’ll learn how to:

Tuesday July 9 – Session#1: 1pm ET/10am PT

IPA general overview
Upload your dataset (RNA-seq, scRNA-seq, proteomics, metabolomics and more)
Set up core/pathway analysis in IPA

Wednesday July 10 – Session#2: 1pm ET/10am PT

Understand the different result types produced (pathways, key regulators, and more)
Customize chart outputs using filters and different chart types like a volcano plot like bubble chart

Thursday July 11 – Session#3: 1pm ET/10am PT

Compare different experimental conditions (different ‘omics data, treatments, time points, single-cell clusters, disease types and more) and identify similarities and contrasts
Generate a network even without a dataset or experimental design for hypothesis generation

If you are able to attend, then we will have additional scientists on the call for Q&A. If you are unable to attend, registering will still allow you to view the recordings.

QIAGEN Ingenuity Pathway Analysis (IPA) summer camp - Session#1
2024-07-09 13:00 - 14:00 (America/Halifax) | HSMD-screen-grab-2

QIAGEN Ingenuity Pathway Analysis (IPA) summer camp - Session#1
2024-07-09 13:00 - 14:00 (America/Halifax) | Virtual - Americas - EST, United States

Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors
2024-06-27 13:00 - 14:00 (America/Halifax) | HSMD-screen-grab-2
Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand, targeted next-generation sequencing (NGS) panels are useful in clinical settings for accurate tumor profiling and the identification of essential molecular aberrations for personalized therapies. By focusing only on a subset of genes, targeted NGS is not only a cost-effective solution, but can rapidly deliver insights into a tumor molecular profile.
To address this challenge, a clinical research team led by Dr. Michela Bulfoni at the Istituto di Anatomia Patologica designed custom NGS panels, named “Glioma” and “Routine Diagnostics”, targeting single nucleotide variations, insertions/deletions, fusions, and copy number variations of tumor-associated essential genes.
In this webinar, attendees will:
Understand the clinical utility of custom-designed NGS panels for accurate tumour diagnosis
Learn about the design and application of these NGS panels
Gain insights into the cost-effectiveness and high sensitivity of NGS panels in improving sample throughput

Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors
2024-06-27 13:00 - 14:00 (America/Halifax) | Virtual - Americas - EST, United States

RNA-seq data analysis and interpretation with sankey plot update
2024-06-25 13:00 - 14:30 (America/Halifax) | Virtual - Americas - EST, United States
For RNA-seq data, you will learn how to:
• Import FASTQ files, cell matrix files and metadata and how to download references
• Map reads to a reference genome and generate gene and transcript counts and QC reports displaying % mapped reads, knee plots, etc.
• Generate visualizations of results, such as heatmaps, differential expression tables, PCA/PCOA plots, Venn diagrams, sankey plot and others
• Easily customize RNA-seq workflows
• Export publication-quality graphics, tables and reports
• Send differential expression tables to QIAGEN Ingenuity Pathway Analysis directly from QIAGEN CLC Genomics Workbench to analyze and interpret relevant pathways
Learn more about CLC or request a free trial: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-clc-workbench-premium/

QIAGEN Ingenuity Pathway Analysis (IPA) for grant writing and publications with new features
2024-06-20 13:00 - 15:00 (America/Halifax) | Virtual - Americas - EST, United States
QIAGEN Ingenuity Pathway Analysis (IPA) is more than just an analysis program; it can also help you write grants and publications. IPA provides biological insights backed by expert-curated findings and thousands of pre-analyzed multiomics datasets. You can search for existing knowledge on molecules of interest, build networks and review results from public studies. Or you can identify key pathways, regulatory molecules and functional changes in your results and see how your data relates to published studies.
Join us to learn how to:
• Search IPA’s vast collection of curated literature and omics data
• Relate molecules to phenotypes and functions
• Build your own networks and predict activity changes
• Explore a library of over 90,000 precomputed IPA analyses pulled from publicly available studies
• Format your dataset and set up an analysis
• Deeply interrogate key Canonical Pathways
• Predict regulators causing your observed expression changes
• Contextualize your results by comparing them to internal and public data
• Generate the necessary tables and figures for your manuscript
Do you already have an IPA license? Install IPA and start using it now: https://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI
Learn more about IPA or request a free trial: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/

Leveraging the QIAGEN Knowledge Graph and causal embeddings for insights into drug repurposing
2024-06-18 13:00 - 14:30 (America/Halifax) | HSMD-screen-grab-2
By connecting diverse entities and relationships, biomedical knowledge graphs hold the potential to uncover new insights from existing data. This webinar introduces a machine learning-based approach that utilizes causal interactions from the QIAGEN Knowledge Graph to predict novel drug-disease relationships and construct networks that capture relevant supporting evidence. We will present examples that showcase the application of this approach in the context of drug repurposing.

Leveraging the QIAGEN Knowledge Graph and causal embeddings for insights into drug repurposing
2024-06-18 13:00 - 14:30 (America/Halifax) | Virtual - Americas - EST, United States

HGMD Pro in action: Search, curate and classify genetic variants - Session 2
2024-06-18 13:00 - 14:00 (America/Halifax) | HSMD-screen-grab-2
In this live, interactive training session, our technical expert will show you how the Human Gene Mutation Database (HGMD) Professional can help you get better variant data faster.

You will learn how to:
• Differentiate between clinically significant variants and variants of unknown significance (VUS)
• Use batch search vs. advanced search, including their differences
• Curate genes using HGMD Pro’s accurate, up-to-date information
• Determine the predominant type of genetic variant that occurs in a specific gene to understand the genetic mechanisms underlying associated diseases
• Additional topics of interest based on registration feedback

HGMD Pro in action: Search, curate and classify genetic variants - Session 2
2024-06-18 13:00 - 14:00 (America/Halifax) | Virtual - Americas - EST, United States

Accelerating Drug Discovery with Comprehensive Curated Knowledge
2024-06-13 13:00 - 14:00 (America/Halifax) | Virtual - Americas - EST, United States
In the rapidly evolving landscape of drug discovery, the ability to integrate high-quality research findings into knowledge graphs is paramount. For over twenty years, the Ingenuity team with QIAGEN has curated these nodes and relationships. Our QIAGEN Biomedical KB-HD make these data available for consumption outside of Ingenuity Pathway Analysis.
In this talk, we will:
• Explore how to query and leverage this curated data resource to accelerate the drug discovery process.
• Provide live demonstration of the underlying database Biomedical-HD
• Show how the Biomedical KB-HD can be rapidly deployed
• Show how the underlying schema and ontologies could serve as a scaffold for integrating your own research
Overall, this demonstration will show the critical role of knowledge graphs in predicting adverse outcomes and toxicity, highlighting their transformative potential in steering pharmaceutical research and development.
Learn more about Biomedical KB: https://qiagen.showpad.com/share/GmpIJaN5kRfsHRD5WPwgc

How decentralized and small labs can adopt high-throughput NGS analysis with limited time and resource investment
2024-06-13 13:00 - 14:00 (America/Halifax) | Virtual Global Event (Times shown in EST)
Next-generation sequencing (NGS) has rapidly gained popularity as a diagnostic testing approach due to its unparalleled ability to comprehensively analyze genetic information with high throughput and precision. However, decentralized and small labs face significant hurdles when it comes to adopting NGS testing. From high upfront costs associated with acquiring the necessary equipment, to the complexity of bioinformatics tools and compliance management that require specialized expertise in data analysis and data security, adopting NGS poses challenges for labs with limited staff and infrastructure.
To empower small and decentralized labs to easily adopt NGS testing, QIAGEN has launched a new secondary analysis solution for oncology and inherited disease applications that enables high-throughput secondary analysis for use with any clinical NGS data. In this webinar, learn about QCI Secondary Analysis, an agnostic, cloud-based software-as-a-service (SaaS) solution that seamlessly integrates with QCI Interpret, QIAGEN’s clinical variant interpretation and reporting software, to deliver highly scalable and customizable Sample to Insight workflows for oncology and inherited disease applications.
In this webinar, attendees will learn how QCI Secondary Analysis:

Streamlines analysis from a range of assay types, enabling labs to process more sequencing data without extensive time and resource investment.
Ensures the highest degree of isolation and data protection, including compliance with ISO 27001, General Data Protect Regulation (GDPR), and the Health Insurance Portability and Accountability Act (HIPPA) requirements.
Directly connects to QCI Interpret for an integrated and automated FASTQ-to-report workflow with limited hands-on time.

How is AI Changing Pharma R&D?
2024-06-12 10:00 - 11:30 (America/Halifax) | Virtual - Americas - EST, United States
AI has begun to transform and accelerate every step of the drug development lifecycle from target identification to drug discovery and clinical trial design. However, the rapid development and adoption of AI platforms come with its own set of challenges regarding data quality, data privacy, and an evolving regulatory landscape. Panelists in this webinar will share their insights into the major opportunities and challenges facing biopharma leaders today as they continue to evaluate and incorporate new AI tools into their R&D workflows.

Geneset enrichment, target Validation and more through programmatically utilizing high quality biomedical literature findings
2024-06-11 13:00 - 14:00 (America/Halifax) | Virtual - Americas - EST, United States
In this 60-minute session, the trainer will go over how to effectively utilize a relationship database for below applications. In this case, QIAGEN Biomedical Knowledgebase (Biomedical KB – a database containing high-quality relationship literature findings, the same database backing Ingenuity Pathway Analysis/IPA) will be used, but learning can possibly be applied to similar databases as well.
The trainer/QIAGEN team will go over
• Conducting Geneset Enrichment Analysis (GSEA)
• How multiple Geneset enrichment methods can be used instead of only those integrated in software GUI
• Target Validation at cell, tissue, and organ level
• Potentially other use cases, queries, and applications requested by registrants
Learn more about Biomedical KB: https://qiagen.showpad.com/share/GmpIJaN5kRfsHRD5WPwgc

QIAGEN Ingenuity Pathway Analysis (IPA) new user training
2024-06-06 13:00 - 14:30 (America/New_York) | Virtual - Americas - EST, United States
Large dataset analysis and exploring the knowledge base using QIAGEN Ingenuity Pathway Analysis (IPA)
Join us for a 120-minute training session for new users of QIAGEN IPA.
In this training, you’ll learn how to:
• Upload your dataset (RNA-seq, scRNA-seq, proteomics, metabolomics and more) and perform interactive core/pathway analysis in IPA
• Understand the different result types produced (pathways, key regulators, impact on biological functions/diseases and more)
• Compare different experimental conditions (treatments, time points, single-cell clusters, disease types and more) and identify similarities and contrasts
• Generate a network even without a dataset or experimental design for hypothesis generation
For those with IPA licenses: download the installer from the link below to install IPA before or after the training.
https://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI
To learn more about IPA or request a trial: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/?cmpid=CM_QDI_DISC_042024webinars-NUT

Investigating genomic variants using QIAGEN CLC Genomics Workbench, QCI Interpret Translational (QCIIT), and QIAGEN Ingenuity Pathway Analysis (IPA)
2024-06-06 13:00 - 14:00 (America/New_York) | Virtual - Americas - EST, United States
Discovering new genes implicated in hereditary diseases or cancer progression is challenging yet advancing rapidly due to the increase in next-generation sequencing (NGS) cohort data. These data analyses produce insights into associations between gene variants and diseases and the biological mechanisms of these gene variants.
By combining QIAGEN CLC Genomics Workbench, QCIIT and QIAGEN IPA, you can analyze sequencing data obtained from a variety of NGS technologies, annotate gene variants using the world’s most comprehensive and up-to-date curated scientific evidence and find biological connections in gene variants with manually curated scientific findings. Using a streamlined NGS analysis workflow, you’ll get valuable and reliable insights for your research project and speed up your discoveries.
In this training, you’ll:

Learn to import whole genome or exome sequencing data into QIAGEN CLC Genomics Workbench and use the ultra-fast LightSpeed Module that delivers an end-to-end NGS FASTQ to VCF pipeline
Explore the capabilities in QCIIT which can help accelerate your discoveries from hereditary or tumor cohort analyses to find associations between gene variants and diseases
Learn how to use QIAGEN IPA and its manually curated content, among other integrated scientific evidence, to uncover novel biological mechanisms underlying these gene variants

HGMD Pro in action: Search, curate and classify genetic variants - Session 1
2024-06-04 13:00 - 14:00 (America/Halifax) | Virtual - Americas - EST, United States

Discovery from public data (GEO, SRA and more) using Ingenuity Pathway Analysis
2024-05-28 13:00 - 14:30 (America/New_York) | Virtual - Americas - EST, United States
Per public demand, we are hosting a comprehensive training on how to effectively use sample level public data and metadata from sources like GEO, SRA, TCGA, GTEx, Blueprint, CCLE and other sources through Ingenuity Pathway Analysis (IPA) and IPA Analysis Match Explorer feature. The trainer will walk through use cases in realms of biomarker discovery, drug–target investigation, studying survival in custom patient cohorts, multi-gene correlation and more.
Note: The word “condition” below refers to different diseases, disease subtypes, treatments, cell types, cell lines and more.
This training will cover topics like
• How is a gene of interest expressed across different conditions?
• Is there a correlation in the expression of two genes or biomarkers of interest for a given condition?
• For a given condition of interest, can we derive a list of genes (example genes specific to a disease, treatment or cell type)?
• Can we generate custom cohorts of patients (example TP53 wt vs mutant or PDCD1 high vs low expression) and then generate survival curves representing those cohorts? Can we generate p-values to see if there is significant difference?
• Can we detect expression of a gene in different cell types from single cell data?

Streamline H5N1 and other microbial samples with CLC Genomics Workbench
2024-05-23 13:00 - 14:30 (America/New_York) | Virtual - Americas - EST, United States
In this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an example, but similar analysis can be done with other viral and microbial (bacteria, fungus and more) samples.
Using viral samples, you will learn how to:
• Utilize molecular biology tools such as primer design, cloning, alignment and tree construction and Sanger sequencing analysis
• Profile the virus present in a sample and automatically generate read mappings, detect variants, annotate consensus sequences, BLAST annotated consensus sequence genes and build phylogenetic trees for top hits and their close relatives
• Microbial genomics analysis including OTU clustering, taxonomic profiling and functional analysis
• Additional topics of interest based on registration feedback
QIAGEN CLC Genomics Workbench is a user-friendly bioinformatics software solutions for genomics, transcriptomics, epigenomics and metagenomics analysis in one program.

Scale up NGS bioinformatics analysis throughput with CLC Genomics Server and Cloud solutions
2024-05-22 13:00 - 14:30 (America/New_York) | Virtual - Americas - EST, United States
More and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and powerful setup for running your NGS sequence analyses through servers or Amazon Web Services (AWS), depending on user preference. We will demonstrate how CLC Genomics Workbench can be used to customize workflows and send analyses for batch execution. We will also highlight analysis automation solutions, use of third-party dockers, audit trails and user management – all of which are available with the CLC Genomics Server software.
You will learn to:
• Customize template workflows to meet your NGS analysis requirements
• Set up a CLC Genomics Cloud environment on AWS
• Submit workflows to run on internal servers or AWS and retrieve results from these analyses
• Use third-party dockers and automate workflow execution
To learn more:
CLC Genomics Server: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/enterprise-ngs-solutions/qiagen-clc-genomics-server/?cmpid=CM_QDI_DISC_052024webinars
CLC Genomics Cloud Module: https://digitalinsights.qiagen.com/plugins/clc-cloud-module/?cmpid=CM_QDI_DISC_052024webinars

Isolate typing, strain identification and anti-microbial resistance analyses using CLC Genomics Workbench
2024-05-21 13:00 - 14:00 (America/New_York) | Virtual - Americas - EST, United States
QIAGEN CLC Genomics Workbench provides tools and workflows for a broad range of bioinformatics applications, including microbiome analysis, isolate characterization through SNP and K-mer trees using NGS data, and antimicrobial resistance characterization. CLC Genomics Workbench is widely used for analyses of bacterial, viral and eukaryotic (fungal) genomes and metagenomes.
Topics covered in this webinar include:
I. Overview of different tools within MGM application and research areas supported
II. Focused review of isolate typing and characterization
a. Importing data
b. Utilization of metadata
c. Downloading and managing references
i. Database of Isolates/ Resistances/ MLST
d. Walk through of Type a Known Species workflow
i. Review details for each Isolate
e. Creating SNP profiles to specific reference
f. Generate a SNP tree for isolate comparison
g. Export tabular and high-quality graphical outputs in wide range of file formats

Clinician’s Roundtable: Interpreting genomic test results for precision oncology
2024-05-16 13:30 - 15:30 (America/New_York) | Virtual Global Event (Times shown in EST)
You’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medicine programs, molecular pathology labs must overcome challenges in genomic test interpretation to ensure maximum clinical utility of molecular profiling results. At this event, hear from clinicians at leading universities and organizations as they present real-world case studies of how molecular pathology labs can improve test turnaround, standardize test interpretation, and deliver comprehensive genomic reports with personalized diagnostic, prognostic, and therapeutic information for each patient.
The free-to-attend virtual event will consist of four educational parts:
1. Case Presentations: Clinicians from Dana Farber Cancer Institute and the National Cancer Institute will present cases of how their labs have overcome challenges in genomic test interpretation.
2. Live Q&A Session: Attendees will have the opportunity to ask the clinicians questions about their experiences implementing precision oncology programs at their institutions.
3. Solution Showcase: In a brief presentation, experts from QIAGEN Digital Insights will showcase our leading Sample to Insight solutions for molecular tumor profiling.
4. Future Forecast: The event will conclude with a short presentation about how molecular tumor profiling will change in the next five years and how labs can leverage new technologies to improve patient care.
→ Learn more about the 2024 Clinician’s Roundtable here.

Leveraging the power of API-based omics (RNA-seq, proteomics and more) queries for discovery
2024-05-16 13:00 - 14:00 (America/New_York) | Virtual - Americas - EST, United States
There is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This webinar, aimed at data scientists, bioinformaticians and similar roles in biopharma and academia, explores a comprehensive way of accessing and analyzing high-quality, expertly curated omics data via the QIAGEN OmicSoft APIs. These OmicSoft APIs provide a powerful and flexible platform for discovering, retrieving, filtering, analyzing and visualizing multi-omic data. You can learn how to access the OmicSoft APIs and programmatically leverage extensive metadata to perform custom analyses and identify targets of interest.
Topics to be covered in this webinar:
• Leveraging curated metadata to structure queries (metadata refers to cell type, tissue, disease, drug treatment etc., associated with public data)
• Finding multiple samples with the same metadata and creating cohorts
• Identifying expression and correlation
• Performing gene set enrichment analysis
• Testing cell specificity with custom aggregation
Please note that the above agenda may be altered per attendee feedback, as we wish to cover what is most relevant to you.
To learn more about OmicSoft data: https://digitalinsights.qiagen.com/news/blog/discovery/boost-your-agility-and-speed-in-drug-development/?cmpid=CM_QDI_DISC_052024webinars-OPI

Mitigating Variability in Somatic Variant Interpretation with Live Q&A
2024-05-15 13:30 - 14:30 (America/New_York) | Virtual - Americas - EST, United States
Next-generation sequencing (NGS) oncology panels are becoming integral in hospital and academic settings to guide patient treatment and enrollment in clinical trials. But as NGS is increasingly used in precision oncology and an unprecedented amount of genomic information is uncovered, there is an industry-wide issue of standardization: a high degree of variability in variant interpretation currently exists across laboratories.
Inconsistencies in variant interpretation among laboratories can create confusion for clinicians and their patients, leaving them unable to confidently use genetic information to manage healthcare decisions. In this live panel discussion, experts in NGS testing and clinical informatics explore the issues surrounding the standardization of variant interpretation and consider how interpretation guidelines and clinical decision support (CDS) software can help to mitigate variability between laboratories.
Topics of discussion will include:
• Findings of a peer-reviewed study comparing the accuracy and consistency of variant assessments from commercial CDS software to the internal variant interpretation methods of eight laboratories.
• Causes of inter-laboratory inconsistency in variant interpretation and how to mitigate variability.
• The benefits of having an up-to-date, high-quality knowledge base to produce consistent, evidence-based clinical classifications.

QIAGEN Biomedical Knowledge Base: data- and analytics-driven drug discovery
2024-05-14 13:00 - 14:30 (America/New_York) | Virtual - Americas - EST, United States
Ingenuity pathway analysis (IPA) which is currently cited in tens of thousands of publications and used by large number of biopharmaceuticals is backed by QIAGEN Biomedical Knowledgebase. Accordingly, Biomedical relationships knowledge has more or less become a requirement for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many more applications.
In this 1hr webinar, the speaker will introduce Biomedical Knowledgebase and how it allows its users to tackle applications that are not doable by Ingenuity Pathway Analysis graphical user interface or can be done faster and with more flexibility programmatically. The speaker will demonstrate queries such as
• Quickly find the shortest connections between genes/proteins/metabolites of interest in the context of specific disease through queries
• Systematically build a network given a short list genes/proteins/metabolites/chemicals
• Recreate a drug mechanism of action
Note: Per feedback of registrants, we may edit above topics as we would like to cover what would be most relevant to you.

International Symposium of Variants 2024
2024-05-13 - 2024-05-15 | Porto, Porto, Portugal

New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
2024-05-07 13:00 - 15:00 (America/New_York) | Virtual - Americas - EST, United States
Join us for a 120-minute training session for new users of QIAGEN IPA.
In this training, you’ll learn how to:
• Upload your dataset (RNA-seq, scRNA-seq, proteomics, metabolomics and more) and perform interactive core/pathway analysis in IPA
• Understand the different result types produced (pathways, key regulators, impact on biological functions/diseases and more)
• Compare different experimental conditions (treatments, time points, single-cell clusters, disease types and more) and identify similarities and contrasts
• Generate a network even without a dataset or experimental design for hypothesis generation
For those with IPA license,
To install IPA before or after this training, please use below installer.
https://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI

Network construction and customization with QIAGEN Ingenuity Pathway Analysis
2024-05-02 13:00 - 14:30 (America/New_York) | Virtual - Americas - EST, United States
Per attendees’ requests from a recent training, we are hosting this in-depth training focused on effectively constructing a network, with or without a dataset (RNA-seq, proteomics, etc.), and easily modifying it – all within Ingenuity Pathway Analysis.
In this interactive training, attendees will learn how to:
• Construct a network from scratch or open a network/pathway of interest from their analysis or the Ingenuity Knowledge Base
• Effectively use tools present in the Build and Overlay menus to add molecules (genes/proteins, chemicals, metabolites), biological processes/diseases of their interest and more
• Modify the network (e.g., to keep only a specific type of relationship like activation, phosphorylation, protein-protein binding and more)
• Perform in silico prediction (e.g., if a drug, siRNA or CRISPR were to reduce the activity of a gene/protein, how will it impact the remaining genes/proteins/diseases in that network)
• Export high-resolution graphics or tabular relationships and make the created network usable in future pathway analysis
Additional QIAGEN Digital Insights (QDI) scientists will be on the call to answer your questions and help with other concerns, such as installing the software.
To learn more about IPA or request a trial: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/?cmpid=CM_QDI_DISC_052024webinars-network

IPA deep dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)
2024-04-30 13:00 - 14:30 (America/New_York) | Virtual - Americas - EST, United States
In this 90-minute training session, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functions, tissues and cell types.
We’ll cover topics such as:
• How to analyze miRNA-seq datasets alone or both miRNA and corresponding mRNA datasets together
• How to use QIAGEN IPA without a dataset, using miRNA IDs
• Introduction to databases and curated content specific to miRNA
• How to effectively apply various filters and functionalities to identify biomarkers, key targets and biological mechanisms
To learn more about IPA or request for a trial:
https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/?cmpid=CM_QDI_DISC_042024webinars-miRNA
